阿尔尼拉姆制药公司与Inceptive公司宣布,双方已建立一项战略性的AI合作。这一联手旨在显著提升RNA干扰疗法的研发进程。
通过整合先进的生成式人工智能技术,两家公司将共同致力于发现与设计下一代RNAi疗法。此举有望缩短药物开发周期,为患者带来突破性的治疗选择。
阿尔尼拉姆制药公司与Inceptive公司宣布,双方已建立一项战略性的AI合作。这一联手旨在显著提升RNA干扰疗法的研发进程。
通过整合先进的生成式人工智能技术,两家公司将共同致力于发现与设计下一代RNAi疗法。此举有望缩短药物开发周期,为患者带来突破性的治疗选择。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.